The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.
Int Immunol. 2010 Nov;22(11):875-87. doi: 10.1093/intimm/dxq441. Epub 2010 Nov 8.
Follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and primary central nervous system lymphoma are B cell malignancies. FL and DLBCL have a germinal center origin. We have applied mutational analyses and a novel algorithm for quantifying shape properties of mutational lineage trees to investigate the nature of the diversification, somatic hypermutation and selection processes that affect B cell clones in these malignancies and reveal whether they differ from normal responses. Lineage tree analysis demonstrated higher diversification and mutations per cell in the lymphoma clones. This was caused solely by the longer diversification times of the malignant clones, as their recent diversification processes were similar to those of normal responses, implying similar mutation frequencies. Since previous analyses of antigen-driven selection were shown to yield false positives, we performed a corrected analysis of replacement and silent mutation patterns, which revealed selection against replacement mutations in the framework regions, responsible for the structural integrity of the B cell receptor, but not for positive selection for replacements in the complementary determining regions. Most replacements, however, were neutral or conservative, suggesting that if at all selection operates in these malignancies it is for structural B cell receptor integrity but not for antigen binding.
滤泡性淋巴瘤 (FL)、弥漫性大 B 细胞淋巴瘤 (DLBCL) 和原发性中枢神经系统淋巴瘤是 B 细胞恶性肿瘤。FL 和 DLBCL 起源于生发中心。我们应用突变分析和一种新的算法来量化突变谱系树的形状特性,以研究影响这些恶性肿瘤中 B 细胞克隆的多样化、体细胞超突变和选择过程的性质,并揭示它们是否与正常反应不同。谱系树分析表明,淋巴瘤克隆中的多样化和每个细胞的突变更多。这仅仅是由于恶性克隆的多样化时间更长,因为它们最近的多样化过程与正常反应相似,这意味着相似的突变频率。由于先前对抗原驱动选择的分析显示会产生假阳性,因此我们对替换和沉默突变模式进行了修正分析,这表明对负责 B 细胞受体结构完整性的框架区中的替换突变存在选择,但对互补决定区中的替换突变不存在阳性选择。然而,大多数替换是中性或保守的,这表明如果在这些恶性肿瘤中确实存在选择,那也是为了 B 细胞受体的结构完整性,而不是为了抗原结合。